Anticorps Monoclonal anti-Apolipoprotein A II/APOA2

Apolipoprotein A II/APOA2 Monoclonal Antibody for WB, IHC, Indirect ELISA

Hôte / Isotype

Mouse / IgG2b

Réactivité testée

Humain

Applications

WB, IHC, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1G1A2

N° de cat : 66773-1-PBS

Synonymes

APOA2, apolipoprotein A II, ApoA-II, Apo-AII, ApoA II



Informations sur le produit

66773-1-PBS cible Apolipoprotein A II/APOA2 dans les applications de WB, IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG2b
Clonalité Monoclonal
Type Anticorps
Immunogène Apolipoprotein A II/APOA2 Protéine recombinante Ag9863
Nom complet apolipoprotein A-II
Masse moléculaire calculée 100 aa, 11 kDa
Poids moléculaire observé 8-11 kDa
Numéro d’acquisition GenBankBC005282
Symbole du gène APOA2
Identification du gène (NCBI) 336
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Apolipoprotein A-II (APOA2) is a major component of high density lipoprotein (HDL) and it plays an important role in directing the fate of lipid metabolism among HDL. It is primarily synthesized by liver. The predicted MW of ApoA2 is 11 kDa, while the mature form is smaller (7-10 kDa) since the signal peptide was cleaved. In humans, most of circulating apoA2 exist as dimer. Five types of APOA2 dimer exist: homodimer apoA2-ATQ/ATQ, heterodimer apoA2-ATQ/AT, homodimer apoA2-AT/AT, apoA2-AT/A, and apoA2-A/A. ApoA2 isoforms are considered to be some of the most promising serum/plasma biomarkers for aiding the early detection of pancreatic cancer. (PMID: 29081441, 29481802)

{{ptg:RelatedPrimaryAntibodies}}